Metformin reduced the risk of basal cell carcinoma across all sex and ethnicity groups, the researchers found. For squamous cell carcinoma patients, though, the lines weren’t as clear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback